A fireside chat, this time by an actual fire! Our conversation with Dr Charlotte Lee-Sinclair is a must-read on DTx challenges and the road to go-to-market in the UK. Read here.

You've probably heard of decentralised clinical trials, but there are a lot of myths out there. Here we debunk the 3 biggest myths.

Depending on your background, our 6 to 8 week product release cycle will evoke one of two reactions. If you work in the clinical space: Woah, what an incredibly fast release cycle! But if you work in a typical SaaS startup: How quaint, I release 3 times a day! Heard of Daniel Kahnemann's bestseller Thinking, Fast and Slow? Well, there is our inspiration!

In the name of science, our co-founder, Meri Beckwith, took intravenous ketamine as part of a clinical trial. Find out what he has learnt about clinical trial design from his most recent trial experience.

Longevity and the halt of decline may sound like the stuff of dreams that many chase in expensive face creams. But not for Alex Zhavoronkov, a spearhead in ageing and longevity and founder of Insilico Medicine. Read our fireside chat here to learn about Alex's pioneering work in this field.

It is no secret that many challenges are associated with using open source trial data in machine learning. Read here to find out what we are doing to innovate ML-powered tools to fuel our clinical trials.